financetom
Business
financetom
/
Business
/
US, EU trade war would only have losers, German finance minister says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US, EU trade war would only have losers, German finance minister says
Oct 26, 2024 6:20 AM

WASHINGTON (Reuters) - A trade conflict between the United States and the European Union would not see any winner but only losers, German Finance Minister Christian Lindner told Reuters in an interview.

Lindner said he was following the toss-up U.S. presidential race between Republican Donald Trump and Democrat Kamala Harris, and saw the risk of tariffs in the next U.S. administration.

"Whoever will enter the White House, we are at the forefront of a new era of transatlantic diplomacy to convince our U.S. partners that we need more or less a new trade agreement between the US and the EU instead of introducing tariffs," Lindner said.

Beyond tariffs, Trump has vowed to "get out" of the nearly three-year war between Ukraine and Russia. That threat helped to motivate the current U.S. administration of Democrat Joe Biden to finalise its $20 billion portion of a long-awaited $50 billion loan to Ukraine backed by frozen Russian assets.

The U.S. announced on Wednesday plans to start making funds available by year-end for economic and military aid. This will be placed alongside a separate $20 billion European Union commitment and $10 billion to be split by G7 allies Britain, Japan and Canada.

Lindner said the EU is finishing the technical details of its portion, but it is "more or less finalised on the political level."

"We have seen a breakthrough this week," Lindner said on the sidelines of the International Monetary Fund and World Bank annual meetings. "It is a symbol of unity among the G7 and the European Union and it is a strong message to (Russian President Vladimir) Putin that we stand with Ukraine as long as it takes."

Lindner told Reuters there will be an announcement on the EU side very soon, without giving further details.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved